Summary
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Eligibility
- Unrestricted
- State Governments
- Independent School Districts
- Private Institutions of Higher Education
- City Or Township Governments
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Public and Indian Housing Authorities
- Nonprofits Non Higher Education Without 501c3
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- Public and State Institutions of Higher Education
- County Governments
- Small Businesses
- Special District Governments
- For Profit Organizations Other Than Small Businesses
- Native American Tribal Governments Federally Recognized
Funding categories
- Consumer Protection
- Agriculture
- Food and Nutrition
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record